ADVANCED RENAL CELL CARCINOMA WITH CLEAR CELL COMPONENT
Clinical trials for ADVANCED RENAL CELL CARCINOMA WITH CLEAR CELL COMPONENT explained in plain language.
Never miss a new study
Get alerted when new ADVANCED RENAL CELL CARCINOMA WITH CLEAR CELL COMPONENT trials appear
Sign up with your email to follow new studies for ADVANCED RENAL CELL CARCINOMA WITH CLEAR CELL COMPONENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to fight advanced kidney cancer
Disease control Recruiting nowThis study tests whether a combination of two oral drugs, belzutifan and zanzalintinib, works better than the current standard drug cabozantinib for people with advanced kidney cancer that has come back after prior treatment. About 904 participants will be randomly assigned to on…
Matched conditions: ADVANCED RENAL CELL CARCINOMA WITH CLEAR CELL COMPONENT
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill combo aims to fight advanced kidney cancer
Disease control Recruiting nowThis Phase 3 trial is testing whether adding the drug zanzalintinib to belzutifan helps people with advanced kidney cancer live longer and keep the cancer from growing. About 758 participants who have already tried standard treatments will receive either the combination or belzut…
Matched conditions: ADVANCED RENAL CELL CARCINOMA WITH CLEAR CELL COMPONENT
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC